{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:40:05Z","timestamp":1759066805019,"version":"3.44.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbr.2020.112804","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T09:58:15Z","timestamp":1594547895000},"page":"112804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The macrocyclic lactones ivermectin and moxidectin show differential effects on rotational behavior in the 6-hydroxydopamine mouse model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"393","author":[{"given":"Alicia M.P.","family":"Warnecke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon S.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Jakowec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryl L.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.bbr.2020.112804_bib0005","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJM197305242882108","article-title":"Start hesitation--a side effect of long-term levodopa therapy","volume":"288","author":"Ambani","year":"1973","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bbr.2020.112804_bib0010","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/mds.27340","article-title":"Medical and surgical management of advanced Parkinson\u2019s disease","volume":"33","author":"Antonini","year":"2018","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.bbr.2020.112804_bib0015","first-page":"229","article-title":"Levodopa in the treatment of Parkinson\u2019s disease: an old drug still going strong","author":"Poewe","year":"2010","journal-title":"Clin. Interv. Aging"},{"issue":"2","key":"10.1016\/j.bbr.2020.112804_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0306-9877(03)00318-9","article-title":"The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson\u2019s disease, multiple sclerosis and amyotrophic lateral sclerosis","volume":"62","author":"Foster","year":"2004","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbr.2020.112804_bib0025","series-title":"Patterning and Cell Type Specification in the Developing CNS and PNS","first-page":"435","article-title":"The generation of midbrain dopaminergic neurons","author":"Ang","year":"2013"},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1602\/neurorx.1.1.139","article-title":"Neurodegeneration and neuroprotection in Parkinson disease","volume":"1","author":"Fahn","year":"2004","journal-title":"NeuroRx"},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/mds.27063","article-title":"Projection of the prevalence of Parkinson\u2019s disease in the coming decades: revisited","volume":"33","author":"Rossi","year":"2018","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.bbr.2020.112804_bib0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mds.25292","article-title":"The current and projected economic burden of Parkinson\u2019s disease in the United States","volume":"28","author":"Kowal","year":"2013","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.bbr.2020.112804_bib0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11302-007-9069-8","article-title":"Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: an immunohistological study","volume":"3","author":"Amadio","year":"2007","journal-title":"Purinergic Signal."},{"issue":"34","key":"10.1016\/j.bbr.2020.112804_bib0050","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1523\/JNEUROSCI.1496-16.2016","article-title":"P2X4 receptor reporter mice: sparse brain expression and feeding-related presynaptic facilitation in the arcuate nucleus","volume":"36","author":"Xu","year":"2016","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bbr.2020.112804_bib0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1017\/S1461145713001703","article-title":"Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders","volume":"17","author":"Asatryan","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2020.112804_bib0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pneurobio.2011.08.006","article-title":"Purinergic signalling: from normal behaviour to pathological brain function","volume":"95","author":"Burnstock","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbr.2020.112804_bib0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnins.2014.00176","article-title":"P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and\/or treat alcohol use disorders","volume":"8","author":"Franklin","year":"2014","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/jnc.13734","article-title":"Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors","volume":"139","author":"Khoja","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2020.112804_bib0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brainres.2019.05.025","article-title":"The expression of purinergic P2X4 and P2X7 receptors in selected mesolimbic structures during morphine withdrawal in rats","volume":"1719","author":"Metryka","year":"2019","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.108.139766","article-title":"Purinergic type 2 receptors at GABAergic synapses on ventral tegmental area dopamine neurons are targets for ethanol action","volume":"327","author":"Xiao","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbr.2020.112804_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2006.08.084","article-title":"Identification of P2X4 receptor-specific residues contributing to the ivermectin effects on channel deactivation","volume":"349","author":"Jel\u00ednkov\u00e1","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bbr.2020.112804_bib0090","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1471-4159.2007.04616.x","article-title":"Role of aromatic and charged ectodomain residues in the P2X(4) receptor functions","volume":"102","author":"Zemkova","year":"2007","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.bbr.2020.112804_bib0095","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1523\/JNEUROSCI.19-17-07289.1999","article-title":"Allosteric control of gating and kinetics at P2X(4) receptor channels","volume":"19","author":"Khakh","year":"1999","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2020.112804_bib0100","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.110.167908","article-title":"Ivermectin antagonizes ethanol inhibition in purinergic P2X4 receptors","volume":"334","author":"Asatryan","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2020.112804_bib0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuropharm.2016.09.016","article-title":"Preclinical development of moxidectin as a novel therapeutic for alcohol use disorder","volume":"113","author":"Huynh","year":"2017","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.bbr.2020.112804_bib0110","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00213-018-4869-9","article-title":"Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders","volume":"235","author":"Khoja","year":"2018","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2020.112804_bib0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2012.03.014","article-title":"Ivermectin reduces alcohol intake and preference in mice","volume":"63","author":"Yardley","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2020.112804_bib0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.alcohol.2017.09.004","article-title":"Reduced expression of purinergic P2X4 receptors increases voluntary ethanol intake in C57BL\/6J mice","volume":"68","author":"Khoja","year":"2018","journal-title":"Alcohol"},{"issue":"6","key":"10.1016\/j.bbr.2020.112804_bib0125","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s11064-014-1271-9","article-title":"Contribution of P2X4 receptors to ethanol intake in male C57BL\/6 mice","volume":"39","author":"Wyatt","year":"2014","journal-title":"Neurochem. Res."},{"issue":"13","key":"10.1016\/j.bbr.2020.112804_bib0130","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/WNR.0000000000000211","article-title":"Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humans","volume":"25","author":"Yardley","year":"2014","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2020.112804_bib0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neubiorev.2019.04.003","article-title":"Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders","volume":"102","author":"Ullah","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"33","key":"10.1016\/j.bbr.2020.112804_bib0140","doi-asserted-by":"crossref","first-page":"16577","DOI":"10.1073\/pnas.1900406116","article-title":"Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson\u2019s disease","volume":"116","author":"Lee","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19\u201320","key":"10.1016\/j.bbr.2020.112804_bib0145","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.lfs.2011.03.010","article-title":"The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson\u2019s disease","volume":"88","author":"Baraka","year":"2011","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.bbr.2020.112804_bib0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112804_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2015.03.058","article-title":"The 6-OHDA mouse model of Parkinson\u2019s disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions","volume":"288","author":"Bagga","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2020.112804_bib0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneumeth.2018.10.031","article-title":"Animal models of early-stage Parkinson\u2019s disease and acute dopamine deficiency to study compensatory neurodegenerative mechanisms","volume":"310","author":"Grandi","year":"2018","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.bbr.2020.112804_bib0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson\u2019s disease","volume":"151","author":"Henry","year":"1998","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.bbr.2020.112804_bib0175","first-page":"363","article-title":"Experimental models of Parkinson\u2019s disease: insights from many models","volume":"49","author":"Tolwani","year":"1999","journal-title":"Lab. Anim. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2004.10.004","article-title":"Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson\u2019s disease","volume":"144","author":"Yuan","year":"2005","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.bbr.2020.112804_bib0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(78)90388-6","article-title":"The rotating rodent: a two component system?","volume":"47","author":"Pycock","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112804_bib0190","first-page":"237","article-title":"Chapter V Motor function(s) of the nigrostriatal dopamine system: studies of lesions and behavior","volume":"21","author":"Dunnett","year":"2005"},{"issue":"4","key":"10.1016\/j.bbr.2020.112804_bib0195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1515\/REVNEURO.1994.5.4.331","article-title":"Role of the nucleus accumbens and the striatum in the production of turning behaviour in intact rats","volume":"5","author":"Koshikawa","year":"1994","journal-title":"Rev. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2020.112804_bib0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-2999(93)90264-I","article-title":"Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats","volume":"237","author":"Saigusa","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2020.112804_bib0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"issue":"8","key":"10.1016\/j.bbr.2020.112804_bib0210","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.neuropharm.2004.02.003","article-title":"Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats","volume":"46","author":"Matsuzaki","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2020.112804_bib0215","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15145","article-title":"6-hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata","author":"Vegas-Su\u00e1rez","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2020.112804_bib0220","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1017\/S1461145712000909","article-title":"Pharmacological insights into the role of P2X(4) receptors in behavioural regulation: lessons from ivermectin","volume":"16","author":"Bortolato","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.176990","article-title":"Ethanol is a fast channel inhibitor of P2X4 receptors","volume":"337","author":"Ostrovskaya","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.bbr.2020.112804_bib0230","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1530-0277.2010.01379.x","article-title":"Implication of the purinergic system in alcohol use disorders","volume":"35","author":"Asatryan","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"7","key":"10.1016\/j.bbr.2020.112804_bib0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072471","article-title":"Residues in transmembrane segments of the P2X4 receptor contribute to channel function and ethanol sensitivity","volume":"21","author":"Popova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0240","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1471-4159.2009.06460.x","article-title":"A point mutation in the ectodomain-transmembrane 2 interface eliminates the inhibitory effects of ethanol in P2X4 receptors","volume":"112","author":"Popova","year":"2010","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.bbr.2020.112804_bib0245","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11302-013-9373-4","article-title":"Tryptophan 46 is a site for ethanol and ivermectin action in P2X4 receptors","volume":"9","author":"Popova","year":"2013","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.bbr.2020.112804_bib0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuroscience.2016.05.041","article-title":"The impact of biological sex and sex hormones on cognition in a rat model of early pre-motot Parkinson\u2019s disease","volume":"345","author":"Betancourt","year":"2017","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2020.112804_bib0255","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jnr.23809","article-title":"Understanding the broad influence of sex hormones and sex differences in the brain","volume":"95","author":"McEwen","year":"2017","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2006.07.004","article-title":"Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson\u2019s disease","volume":"174","author":"Field","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2020.112804_bib0265","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbr.2015.01.053","article-title":"A partial lesion model of Parkinson\u2019s disease in mice--characterization of a 6-OHDA-induced medial forebrain bundle lesion","volume":"284","author":"Boix","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"5\u20136","key":"10.1016\/j.bbr.2020.112804_bib0270","first-page":"513","article-title":"Early pubertal female rats are more resistant than males to 6-hydroxydopamine neurotoxicity and behavioural deficits: a possible role for trophic factors","volume":"25","author":"Pienaar","year":"2007","journal-title":"Restor. Neurol. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0149-7634(86)90029-1","article-title":"Effects of estrogen on the basal ganglia","volume":"10","author":"Vanhartesveldt","year":"1986","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.bbr.2020.112804_bib0280","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s40262-017-0511-y","article-title":"Pharmacokinetics of rytary (R), an extended-release capsule formulation of carbidopa-levodopa","volume":"56","author":"Mittur","year":"2017","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.bbr.2020.112804_bib0285","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JPD-191683","article-title":"Parkinson\u2019s disease in women and men: What\u2019s the difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.bbr.2020.112804_bib0290","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1242\/dmm.028738","article-title":"The role of Ca2+ signaling in Parkinson\u2019s disease","volume":"10","author":"Zaichick","year":"2017","journal-title":"Dis. Model. Mech."},{"issue":"1","key":"10.1016\/j.bbr.2020.112804_bib0295","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuroscience.2008.03.076","article-title":"P2X receptors and synaptic plasticity","volume":"158","author":"Pankratov","year":"2009","journal-title":"Neuroscience"},{"issue":"16","key":"10.1016\/j.bbr.2020.112804_bib0300","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/mds.23388","article-title":"Gender differences in Parkinson\u2019s disease: clinical characteristics and cognition","volume":"25","author":"Miller","year":"2010","journal-title":"Mov. Disord."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820305039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820305039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:27:59Z","timestamp":1759066079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432820305039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":60,"alternative-id":["S0166432820305039"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112804","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The macrocyclic lactones ivermectin and moxidectin show differential effects on rotational behavior in the 6-hydroxydopamine mouse model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112804"}}